STEPHEN B. HOWELL, M.D. - Corporate Board Profile

ABEONA THERAPEUTICS INC.

Filing Date	Source Excerpt
2005-04-18	Stephen B. Howell, M.D. has served as one of our directors since 1996. Dr. Howell is a Professor of Medicine at the University of California, San Diego, and director of the Cancer Pharmacology Program of the UCSD Cancer Center.
2006-04-25	Dr. Howell is a member of the Compensation Committee of the Board. ... Dr. Howell received $79,000 in consulting fees in 2005.
2007-04-13	Stephen B. Howell, M.D. has served as one of our directors since 1996. Dr. Howell is a member of the Compensation Committee of the Board. ... The Compensation Committee is currently comprised of Jeffrey B. Davis (chairman) and Dr. Stephen B. Howell. ... The table below represents the compensation paid to our directors during the year ended December 31, 2006: Stephen B. Howell, MD: Fees earned or Paid in Cash ($) 12,000, Option Awards ($) 6,137, All Other Compensation ($) 69,000, Total ($) 87,137.
2008-04-22	Stephen B. Howell, M.D. has served as one of Access’ directors since 1996. Dr. Howell is a member of the Compensation Committee of the Board and a scientific consultant to the Company. ... Director Compensation Table - 2007: Stephen B. Howell total compensation $84,000.
2009-04-22	Stephen B. Howell, M.D. has served as one of Access’ directors since 1996. Dr. Howell is a member of the Compensation Committee of the Board. ... Stephen B. Howell, MD Fees earned or Paid in Cash ($) 12,000 Option Awards ($)(1) 16,000 All Other Compensation ($) 32,000 Total ($) 60,000.
2010-04-16	Stephen B. Howell, MD (6) - Represents expense recognized in 2009 in respect of options to purchase 35,000 shares of our Common Stock based on a grant date fair value of $40,000. Dr. Howell has options to purchase 79,700 shares of our Common Stock at December 31, 2009.
2011-04-14	Stephen B. Howell, M.D., a Director, is a member of the Compensation Committee. Represents expense recognized in 2010 in respect of options to purchase 30,000 shares of our common stock based on a grant date fair value of $64,000.
2012-04-16	The Compensation Committee is currently comprised of Mr. Mark J. Ahn (chairman) and Dr. Stephen B. Howell. Dr. Howell received options to purchase 35,000 shares of our common stock based on a grant date fair value of $67,000.
2013-04-02	Stephen B. Howell, M.D. has served as our director since 1996. Dr. Howell is a member of the Compensation Committee of the Board. Dr. Howell is a Professor of Medicine at the University of California, San Diego, and director of the Cancer Pharmacology Program of the UCSD Cancer Center. Dr. Howell is a recipient of the Milken Foundation prize for his contributions to the field of cancer chemotherapy. He has served on the National Research Council of the American Cancer Society and is on the editorial boards of multiple medical journals. Dr. Howell founded DepoTech, Inc. and served as a member of its board of directors from 1989 to 1999. Dr. Howell served on the board of directors of Matrix Pharmaceuticals from 2000 to 2002. Dr. Howell received his A.B. at the University of Chicago and his M.D. from Harvard Medical School. Dr. Howell’s qualifications to serve our Board include his technical expertise and strong commitment to promoting and advancing innovation in the healthcare industry. In addition, Dr. Howell’s qualifications include experience as a medical doctor in oncology, his experience as director of several biotech companies and his executive skills and experience as a founder of a biotech company.
2014-04-15	Stephen B. Howell, M.D. has served as our director since 1996. Dr. Howell is a member of the Compensation Committee of the Board.
2015-04-07	Stephen B. Howell, MD 70 Director ... Dr. Howell is a member of the Compensation Committee and Audit Committee of the Board. ... The table below represents the compensation paid to our outside directors during the year ended December 31, 2014: Stephen B. Howell, MD 69,000 ... Dr. Howell has served as our director since 1996.
2016-04-06	Dr. Howell is a member of the Compensation Committee and Nominating and Corporate Governance Committee. ... Dr. Howell received total compensation of $890,000 in 2015.
2017-04-11	Stephen B. Howell, M.D., 72, has served as our director since 1996. Dr. Howell is a member of the Compensation Committee and Nominating and Corporate Governance Committee of the Board. ... The Compensation Committee is currently comprised of Stephen B. Howell, M.D. and Mark J. Alvino. ... The Nominating and Corporate Governance Committee is currently comprised of Mark J. Alvino and Stephen B. Howell, M.D. ... The table below represents the compensation paid to our outside directors during the year ended December 31, 2016: ... Stephen B. Howell, MD ... Total ($) 306,000
2018-04-10	Stephen B. Howell, M.D. 73 Director Dr. Howell is a member of the Compensation Committee and Nominating and Corporate Governance Committee of the Board. Director Compensation Table — 2017 The table below represents the compensation paid to our outside directors during the year ended December 31, 2017: Stephen B. Howell, MD Fees earned or Paid in Cash ($) 40,000 Bonus ($) — Stock Awards ($) — Option Awards ($)(1) 380,000 Total ($) 420,000(3)
2019-04-11	Stephen B. Howell, M.D., 74, has served as our director since 1996 and serves as a member of the Compensation Committee and the Nominating and Corporate Governance Committee.
2020-04-10	Stephen B. Howell, M.D., 75, Director